Skip to main content
. 2012 Dec 26;15(3):154–161. doi: 10.1111/jch.12057

Table 4.

Clinical Epidemiology of Hypertension in NHANES 2007–2008 vs 2009–2010: Impact of Untreated Twice‐Told Hypertensive Patients With Nonhypertensive BP

NHANES 2007–2008 2009–2010
Def A No. 2057 2093 P Value
Prevalence, % 29.0 (27.6–30.5) 28.4 (26.3–30.6) .32
Awareness, % 80.7 (78.2–83.0) 81.1 (78.1–83.8) .41
Treated, % 72.7 (70.3–74.9) 75.8 (72.0–79.2) .06
Controlled, % 50.1 (46.8–53.5) 53.3 (50.3–56.3) .07
<140/<90, <130/<80 DM/CKDa 44.7 (41.0–48.4) 48.4 (45.3–51.4) .05
Def B No. 2221 2284
Prevalence, % 32.2 (30.8–33.7) 31.4 (29.3–33.6) .32
Awareness, % 82.6 (80.1–84.9) 83.0 (80.2–85.5) .41
Treated, % 65.5 (63.4–67.6) 68.6 (65.2–71.8) .06
Controlled, % 55.0 (51.4–58.6) 57.8 (54.8–60.8) .07
<140/<90, <130/<80 DM/CKDa 49.8 (45.9–53.7) 53.2 (50.2–56.2) .05

Abbreviations: Def, Definition; A, excluding and B, including untreated, twice‐told hypertensive with nonhypertensive BP (ntHTN); DM, diabetes mellitus; CKD, chronic kidney disease; NHANES, National Health and Nutrition Examination Surveys. aHypertension control with blood pressure goal <140<90 mm Hg in patients without and <130/<80 mm Hg in patients with DM and/or CKD.